A NEW VACCINE FOR HEPATITIS-B
Hepatitis-B a life threatening liver infection can be tackled by a new vaccine developed.The vaccine was already in the market and used against Grass Pollen Allergies (BM-32).A recent research has shown that the vaccine also offer an effective solution for the combining Hepatitis-B.
The research has been conducted at MedUni Vienna's Institute For Pathophysiology and Allergy Research and has been published in the journal of EBio Medicine.The article was well responded by international experts with their comments.
The new vaccine BM-32 which is synthesized wih an innovative recombinant peptide-carrier technology.
The recombinant vaccine therapy has the advantage over the other conventional vaccine therapy for Hepatitis-B and other allergic conditions by reducing the number injections and side effects.
The Recombinant Peptide Carrier Technology was originally developed at the Christian Doppler Laboratory For Allergy Research at MedUni Vienna under the direction of Rudoff Valenta.
The News
Grass pollen allergy vaccine also effective against hepatitis B
Adapted Media Release
Published: Published: Thu 8 Sep 2016
A new type of vaccine against grass pollen allergies (BM32) might also offer an effective treatment for combating hepatitis B infection. This is the finding of a study conducted at MedUni Vienna's Institute for Pathophysiology and Allergy Research that has now been published in the leading journal EBioMedicine, with a commentary from international experts.
The BM32 vaccine is based on an innovative recombinant peptide-carrier technology, which - compared with other immunotherapies for allergy sufferers - requires far fewer injections and has fewer side-effects. Recombinant peptide-carrier technology was developed at the Christian Doppler Laboratory for Allergy Research at MedUni Vienna, under the direction of Rudolf Valenta. BM32 was developed jointly with commercial partner Biomay AG.
In a Phase IIb study conducted as part of her dissertation at the Institute for Pathophysiology and Allergy Research at MedUni Vienna, Carolin Cornelius discovered that BM32 is also a highly promising treatment option for combating hepatitis B infections. Cornelius: "We were able to show that, in people who had not previously been immunised with a conventional hepatitis B vaccine, vaccination with BM32 achieved an average inhibition of hepatitis B virus infection of 80%. According to the MedUni Vienna researcher, this suggests that the concept of peptide-carrier fusion proteins might also be a potential approach for improving hepatitis B immunisation.
Article: Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection, Carolin Cornelius, Katrin Schöneweis, Fanny Georgi, Milena Weber, Verena Niederberger, Petra Zieglmayer, Katarzyna Niespodziana, Michael Trauner, Harald Hofer, Stephan Urban, Rudolf Valenta, EBioMedicine, doi: 10.1016/j.ebiom.2016.07.023, published online 7 august 2016.
The BM32 vaccine is based on an innovative recombinant peptide-carrier technology, which - compared with other immunotherapies for allergy sufferers - requires far fewer injections and has fewer side-effects. Recombinant peptide-carrier technology was developed at the Christian Doppler Laboratory for Allergy Research at MedUni Vienna, under the direction of Rudolf Valenta. BM32 was developed jointly with commercial partner Biomay AG.
In a Phase IIb study conducted as part of her dissertation at the Institute for Pathophysiology and Allergy Research at MedUni Vienna, Carolin Cornelius discovered that BM32 is also a highly promising treatment option for combating hepatitis B infections. Cornelius: "We were able to show that, in people who had not previously been immunised with a conventional hepatitis B vaccine, vaccination with BM32 achieved an average inhibition of hepatitis B virus infection of 80%. According to the MedUni Vienna researcher, this suggests that the concept of peptide-carrier fusion proteins might also be a potential approach for improving hepatitis B immunisation.
Hepatitis B: up to 10% of those vaccinated conventionally do not have effective antibodies
Cornelius: "Ongoing investigations should help to produce a comprehensive characterisation of the HBV neutralisation capability of BM32. Apart from having a preventive effect, there might be additional benefits for patients suffering from chronic hepatitis B infection. Background: hepatitis B infection is still one of the most widespread health problems in the world. The virus is detectable in the blood of around 350 million people. However, around 5 to 10% of those who have been vaccinated using a conventional vaccine fail to build up an adequate antibody titer. "One can only assume that these people are not protected against infection."Five research clusters at MedUni Vienna
In total, five research clusters have been established at MedUni Vienna. In these clusters, MedUni Vienna is increasingly focusing on fundamental and clinical research. The research clusters include medical imaging, cancer research/oncology, cardiovascular medicine, medical neurosciences and immunology. This paper falls within the remit of the Cluster for Immunology.Article: Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection, Carolin Cornelius, Katrin Schöneweis, Fanny Georgi, Milena Weber, Verena Niederberger, Petra Zieglmayer, Katarzyna Niespodziana, Michael Trauner, Harald Hofer, Stephan Urban, Rudolf Valenta, EBioMedicine, doi: 10.1016/j.ebiom.2016.07.023, published online 7 august 2016.
I want to share my testimony on how i get cure of my Hepatitis disease with the help of Doctor Abumere,i have being suffering for this disease for a very long time now. I have try several means to get rid of the (Hepatitis disease) disease for the last four years and had constant pain, especially in my knees. During the first year, I had faith in God that i would be healed someday. This disease started circulate all over my body and i have been taking treatment from my doctor, few weeks ago i came on search on the internet if I could get any information concerning the prevention of this disease, on my search I saw a testimony of someone who has been healed from (Hepatitis B and Cancer) by this Man DR Abumere and she also gave the email address of this man and advise we should contact him for any sickness that he would be of help, so i wrote to DR Abumere telling him about my (Hepatitis disease) he told me not to worry that i was going to be cured!! hmm I never believed it,, well after all the procedures and remedy given to me by this man few weeks later I started experiencing changes all over me as the Doctor assured me that I am cured, after some time I went to my doctor to confirmed if I have be finally healed behold it was TRUE, So friends my advise is if you have such sickness or any other at all you can email DR Abumere on sir I am indeed grateful for the help I will forever recommend you to my friends and to share this to every one that have any of this sickness. i will advice anyone out there who has any of theses disease to kindly email Dr Abumere(abumereherbalcentre@gmail.com
ReplyDeletethank you